51662-1251-3 : NDC 2026 Code

51662-1251-3 : Phenytoin Sodium ( Phenytoin Sodium )

Additionally :

You can get information about “51662-1251-3” NDC code in 51662-1251-3 in HTML format

HTML | 51662-1251-3 in TXT (Plain Text) format

TXT | 51662-1251-3 in PDF (Portable Document Format)

PDF | 51662-1251-3 in XML format

XML formats.

NDC Code : 51662-1251-3 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51662-1251-3",
    "PackageDescription": "25 POUCH in 1 BOX (51662-1251-3)  / 1 VIAL in 1 POUCH (51662-1251-2)  / 2 mL in 1 VIAL",
    "NDC11Code": "51662-1251-03",
    "ProductNDC": "51662-1251",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Phenytoin Sodium",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Phenytoin Sodium",
    "DosageFormName": "INJECTION",
    "RouteName": "INTRAMUSCULAR; INTRAVENOUS",
    "StartMarketingDate": "20180916",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA084307",
    "LabelerName": "HF Acquisition Co LLC, DBA HealthFirst",
    "SubstanceName": "PHENYTOIN SODIUM",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Anti-epileptic Agent [EPC], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C8 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-01-24",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20220316",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}